Ascendis Pharma A/S Ordinary Share
ASNDNASDAQMarket cap
$14.86B
Employees
1,189
Exchange
NASDAQ
About Ascendis Pharma A/S Ordinary Share
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Country
US
Website
www.ascendispharma.com